Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).

NARecruitingINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

May 20, 2027

Study Completion Date

May 20, 2027

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PSMA PET/CT

The PSMA PET/CT will be performed on an outpatient in the nuclear medicine department of the Brest University Hospital (CHRU). For this exam, the administration of 2-4 MBq/kg of 68Ga-HBED-CC-PSMA or 1,8-2,2 MBq/kg of 68Ga-PSMA-11 will be performed to patient by a single intravenous injection.

Trial Locations (1)

29609

RECRUITING

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER